SETDB2 Peptide | 42-978P

SETDB2 Peptide | 42-978P | Gentaur UK, US & Europe Distribution

Short Description: SETDB2 Peptide

Species: Human

Location: SETDB2 peptide is a 15 amino acid synthetic peptide near the C or N-Terminus of SETDB2.

Tested Application: Bl

Application: SETDB2 Peptide is used for blocking the activity of SETDB2 Antibody (catalog number 42-978). SETDB2 antibody ships at 0.5 mg/mL and the IRF4 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μL water, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.

Physical State: Lyophilized

Buffer: SETDB2 peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 μL water, the concentration will be 0.5 mg/mL.

Concentration: N/A

Storage: Store at -20˚C. When reconstituted minimize freezing and thawing.

NCBI Official Symbol: SETDB2

Alternate Names: CLLD8, CLLL8, KMT1F, C13orf4, CLLD8, Histone-lysine N-methyltransferase SETDB2, Chronic lymphocytic leukemia deletion region gene 8 protein,

NCBI Gene ID: 83852

User Note: N/A

NCBI Official Name: Set Domain, Bifurcated 2

Background: N/A

Disclaimer: This product is for research use only.